« Picosecond Protein Watching |
Main
| JNK3 - Something New for Alzheimer's? »
November 8, 2012
Biotech Takeover Targets
Posted by Derek
From the folks at FierceBiotech, here's a list of the "most frequently cited" takeover targets in the biotech sector. As John Carroll put it, the key seems to be: "targets that include either late-stage blockbuster candidates or some clearly defined new products on the market that can be had for $1 billion to $6 billion." I'll tell you that Onyx is number one on the list, but take a look at the rest and see if you agree. . .
Comments (2)
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- › AstraZeneca's Move To Hot, Happening Cambridge
- › Stealing A Compound, To Set Up in China
- › Tecfidera's Price
- › Novartis Loses the Glivec Patent Fight in India
- › ChemBark Closing Down (Update: Not Really!)
- › Fake Journals - But They'd Like Real Money
- › Chemical Probes Versus Drugs
- › Two New Books
1. SP on November 8, 2012 4:57 PM writes...
Aside from Onyx, all those are in the first half of the alphabet, so if you want to be successful you should definitely name your company something starting with A or B.
Permalink to Comment2. anon2 on November 8, 2012 5:21 PM writes...
Take a lesson from HGS's history----don't be too greedy.
Permalink to Comment